Copy to clipboard 
SINTX Technologies signed a supply agreement whereby EVONIK will manufacture the company’s proprietary silicon nitride–PEEK compound (SiN/PEEK), engineered for AI‑assisted additive manufacturing of patient‑specific implants that will be produced using equipment already in place at SINTX’s U.S.-based production facility.
Under the agreement, EVONIK will produce SiN/PEEK compound leveraging its commercial-scale capability to SINTX’s specifications, enabling the company to immediately begin manufacturing AI‑designed, 3D‑printed, patient‑specific implants. SINTX has already received physician requests to provide humanitarian‑use vertebral body replacement implants following tumor resections in the spine. In addition, the company intends to use the SiN/PEEK compound to support regulatory clearances of patient matched and traditional subtractive manufactured implantable devices.
The companies envision making the SiN/PEEK compound available to other qualified manufacturers for complex implant indications where silicon nitride’s attributes may add clinical and economic value.
SINTX’s near‑term humanitarian efforts are focused on trauma and oncology indications for post‑tumor resection cases, where surgeons face challenging anatomy and infection risk, and where patient‑specific designs may facilitate better fit, fixation and overall clinical outcomes, stated Dr. Ryan Bock, SINTX Chief Technology Officer. “We’re responding to real‑world surgeon requests in oncology‑related care. Our immediate focus is on humanitarian‑use cases while we build the quality systems, regulatory files, and production capacity to expand into additional indications through appropriate FDA pathways.”
Source: SINTX Technologies, Inc.
